Cholestyramine and colestipol are bile acid sequestrants used to lower LDL cholesterol in conjunction with diet and other lipid-lowering agents. They function by binding bile salts in the intestine and promoting increased cholesterol conversion to bile acids, thereby reducing LDL levels. Common adverse effects include gastrointestinal issues and potential drug interactions, necessitating careful timing when administering other medications.